Francesco Ponticelli, Arif A Khokhar, Geert Leenders, Maayan Konigstein, Carlo Zivelonghi, Pierfrancesco Agostoni, Jan-Peter van Kuijk, Issameddine Ajmi, Steven Lindsay, Matjaž Bunc, Matteo Tebaldi, Alessandro Cafaro, Kevin Cheng, Alfonso Ielasi, Tiffany Patterson, Jan Sebastian Wolter, Fabio Sgura, Federico De Marco, Dan Ioanes, Gianpiero D'Amico, Marco Ciardetti, Sergio Berti, Stefano Guarracini, Michele Di Mauro, Guglielmo Gallone, Mirthe Dekker, Max J M Silvis, Giuseppe Tarantini, Simon Redwood, Antonio Colombo, Christoph Liebetrau, Ranil de Silva, Claudio Rapezzi, Roberto Ferrari, Gianluca Campo, Steffen Schnupp, Leo Timmers, Stefan Verheye, Pieter Stella, Shmuel Banai, Francesco Giannini
INTRODUCTION: Refractory angina (RA) is considered the end-stage of coronary artery disease, and often has no interventional treatment options. Coronary sinus Reducer (CSR) is a recent addition to the therapeutic arsenal, but its efficacy has only been evaluated on small populations. The RESOURCE registry provides further insights into this therapy. METHODS: The RESOURCE is an observational, retrospective registry that includes 658 patients with RA from 20 centers in Europe, United Kingdom and Israel...
August 15, 2021: International Journal of Cardiology